Related Experiment Video
Updated: Jul 5, 2026
11:07
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
Published on: November 24, 2021
Cosmetovigilance: the 'beautiful' risk
1Clinical Pharmacology Unit, University of Verona, Verona, Italy. umoretti@sfm.univr.it
Drug Safety
|April 22, 2008
Summary
Cosmetics aim to cleanse or enhance appearance, unlike drugs which treat disease. However, regulatory oversight for cosmetic safety and efficacy is limited, with industry largely responsible for adverse effect monitoring.
Area of Science:
- Cosmetic Science
- Regulatory Affairs
- Dermatology
Background:
- Cosmetics are preparations applied externally for cleansing, enhancing appearance, scent, or protection.
- Unlike drugs, cosmetics are not intended to alter body structure or function, though this distinction can be unclear.
- Current regulations primarily focus on cosmetic product safety for general consumers.
Purpose of the Study:
- To examine the regulatory landscape of cosmetic products.
- To highlight the challenges in ensuring cosmetic safety and efficacy.
- To discuss the industry's role in monitoring adverse effects.
Main Methods:
- Review of existing cosmetic regulations and definitions.
- Analysis of the pre-market approval process for cosmetic products.
- Examination of post-market surveillance and adverse event reporting mechanisms.
Main Results:
- The line between cosmetics and drugs can be ambiguous.
- National authorities do not typically review or approve cosmetic efficacy or safety before market release.
- Adverse effect identification and analysis are largely industry-driven, posing potential conflicts of interest.
Conclusions:
- The regulatory framework for cosmetics emphasizes safety but lacks pre-market approval for efficacy and safety.
- Industry self-regulation in monitoring adverse effects presents inherent conflicts of interest.
- Clearer distinctions and potentially enhanced regulatory oversight are needed for cosmetic products.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:12Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:28Survey Safety
Surveying near highways, rough terrain, or power lines involves significant risks. Working along highways is particularly dangerous and requires the use of warning signs and flagmen. It is safest to avoid working directly on roads and use offsets whenever possible. When highway work is unavoidable, it must follow all safety guidelines. Surveyors should wear bright clothing, such as orange reflective vests, to ensure visibility to motorists, coworkers, and hunters. In construction zones, wearing...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...